NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5)
Estimated value
£608.0m
Awarded value
£608.0m
Awarded 11 Mar 2024
Suppliers
1
Lots
1
1 awarded
Published
03 Apr 2024
Deadline 01 Dec 2023
Other contracts from NHS England· 10
Most recent notices published by the same contracting authority.
| Title | Type | Value | Published |
|---|---|---|---|
| Matrix - Desk Booking System | call off | £105k | 08 May 2026 |
| Telephony 0300 Numbers Renewal (Gamma) 2026 - 2028 | call off | £17k | 08 May 2026 |
| ID&V Checking Service | contract | £150k | 08 May 2026 |
| Xerox Managed Print renewal 26/27 | call off | £127k | 08 May 2026 |
| Manage Engine ServiceDesk Plus Licences | call off | £29k | 08 May 2026 |
| Ccube EDRMS C302203 Annual Maintenance and Support 2025 - 2026 | contract | £105k | 08 May 2026 |
| Clinicals Run Maintain Transform | call off | £38.0m | 10 Apr 2026 |
| Specialised Pharmaceutical Logistics and Warehouse Services for Vaccination & Immunisation Programmes | contract | — | 07 Apr 2026 |
| NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiatives | contract | — | 07 Apr 2026 |
| CPIT System Integration to NHSE RAVS | contract | £500k | 01 Apr 2026 |
Other contracts awarded to ITH Pharma,Qualasept Ltd t/a Bath ASU,Sciensus Pharma Services Limited,Baxter Healthcare Ltd,LloydsPharmacy Clinical Homecare,Quantum Pharmaceutical· 0
Cross-buyer view of this supplier's public-sector wins.
No related contracts found.